##  [AI in Medical Device and IVD Regulatory Writing Efficiency : Enabler or Compliance Risk](/index%2ephp/white-papers/ai-in-medical-device-and-ivd-regulatory-writing-efficiency-enabler-or-compliance-risk) 

- [Medical Devices](/index%2ephp/white-papers-categories/medical-devices)
- [Clinical & Performance Evaluation](/index%2ephp/white-papers-categories/clinical-performance-evaluation)





 ![AI in Medical Device and IVD Regulatory Writing Efficiency Enabler or Compliance Risk]()

AI can accelerate regulatory documentation. But can AI-assisted content withstand Notified Body scrutiny?

For medical device and IVD manufacturers operating under EU MDR and IVDR, Clinical Evaluation Reports, Performance Evaluation Reports, PMS reports, PMCF reports, PMPF reports, and related technical documentation must do more than read well. They must be scientifically valid, evidence-based, traceable, and defensible during regulatory review.

This Freyr white paper explores how AI can support clinical and performance writing while introducing new compliance risks. It examines AI-assisted literature screening, evidence extraction, CER and PER drafting, PMS and PMCF summarization, document consistency review, hallucinated references, traceability gaps, human oversight, QMS integration, and audit readiness.

Because efficiency is valuable in regulatory, clinical and performance writing. But defensibility is essential.



Fill the form below to download the White Paper

 You must have JavaScript enabled to use this form.

  

  

  

 How did you hear about us?Search EngineE-mail CampaignGoogle AdsSocial MediaLink from another websiteColleague’s RecommendationNewsletterPrinted BrochureOther 

  

 

 

     I have read the [privacy policy](https://www.freyrsolutions.com/privacy-policy) 



 

 Submitted Page URL  

 Website URL  

 Content Type  

 Form Name